Clinical Trial Update: Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01) [Phase 2]

View source ↗

Summary

The TraQ-Me 01 Phase 2 feasibility trial of metronomic chemotherapy for locally advanced HER2-positive breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Metronomic chemotherapy (metronomic chemotherapy)

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Locally Advanced HER2-positive Breast Cancer | Phase 2 | Status: TERMINATED